Chongqing Sansheng has announced that it will acquire a 100% interest in Liaoyuan City Baikang Pharmaceutical for a consideration of $40.13m.

The target company is a drug manufacturer, whereas Chongqing Sansheng develops building materials and chemicals.

Recipharm has announced plans to invest its available funds, credit facilities and proceeds from shares issues in a rights offering to acquire certain businesses of a biopharmaceutical contract services company Kemwell Biopharma Pvt Ltd.

The $205.86m acquisition will be funded entirely by Recipharm and will include the target company’s contract development and manufacturing assets in the US, Sweden, India.

The acquisition will enable Recipharm expand its technology and capabilities and international market by developing a strong customer relationship.

Image: Recipharma has annoounced to acquire Kemwell Bipoharma; Photo: courtesy of Kemwell Biopharma.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.